Krishna Instt of Medical Sciences - Krishna Institute of Medical Sciences Share Price

Krishna Instt of Medical Sciences - Krishna Institute of Medical Sciences Share Price

  • 785.1019.71 (2.58%)
  • Closed
  • As On: 12 Jun, 2026, 03:52 PM IST
Loading...
Open776.90
High788.00
Low771.40
Prev Close765.40
Volume4,83,256
VWAP(₹)782.29

Key Metrics

PE Ratio(x)130.14
EPS - TTM(₹)6.03
MCap(₹ Cr.)31,414.91
MCap Rank7
PB Ratio(x)11.94
Div Yield(%)-
Face Value(₹)2.00
52W High(₹)811.00
52W Low(₹)575.80
MCap/Sales6.38
Beta(1 Month)-
BV/Share(₹)63.94

Krishna Instt of Medical Sciences share price insights

  • Board Meeting was held on Jun 13, 2026

    Meeting Agenda: Others. Please add to watchlist to track closely.
  • Beating 3 Yr Revenue CAGR

    Company's annual revenue growth of 28.16% outperformed its 3 year CAGR of 20.68%. (Source: Consolidated Financials)
  • Employee & Interest Expense

    Company has spent 5.19% of its operating revenues towards interest expenses and 17.46% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Krishna Instt of Medical Sciences Share Price Update

    Krishna Institute of Medical Sciences Ltd. share price moved up by 2.58% from its previous close of Rs 765.40. Krishna Institute of Medical Sciences Ltd. stock last traded price is 785.10

    Share PriceValue
    Today/Current/Last785.10
    Previous Day765.40

Found Insights useful?

Krishna Instt of Medical Sciences Share Price Returns

1 Day2.58%
1 Month4.67%
3 Months18.17%
1 Year18.72%
3 Years143.8%
5 YearsN.A.

Krishna Instt of Medical Sciences Share Recommendations

Mean recosCurrent
BUY

13 Analysts

Strong
Sell
SellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy5555
Buy7777
Hold1111
Sell----
Strong Sell----
# Analysts13131313
Recent Recos
  • Target₹3300
  • OrganizationHSBC Asset Management
  • BUY
  • Target₹2200
  • OrganizationPrabhudas Lilladher
  • BUY
  • Target₹2100
  • OrganizationAxis Securities
  • BUY

Financials

  • Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income1,002.90964.90878.70801.40790.20
    Total Income Growth (%)3.949.819.651.421.01
    Total Expenses877.50823.10732.40640.70629.90
    Total Expenses Growth (%)6.6112.3814.311.714.95
    EBIT125.40141.80146.30160.70160.30
    EBIT Growth (%)-11.57-3.08-8.960.25-11.97
    Profit after Tax (PAT)53.4066.9078.60101.8088.70
    PAT Growth (%)-20.18-14.89-22.7914.77-17.41
    EBIT Margin (%)12.5014.7016.6520.0520.29
    Net Profit Margin (%)5.326.938.9512.7011.23
    Basic EPS (₹)1.331.671.962.542.22
    Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income456.20442.50385.60370.10368.10
    Total Income Growth (%)3.1014.764.190.54-0.49
    Total Expenses336.80338.60293.40241.50259.50
    Total Expenses Growth (%)-0.5315.4121.49-6.94-2.52
    EBIT119.40103.9092.20128.60108.60
    EBIT Growth (%)14.9212.69-28.3018.424.73
    Profit after Tax (PAT)72.5063.5058.8093.5076.50
    PAT Growth (%)14.177.99-37.1122.225.96
    EBIT Margin (%)26.1723.4823.9134.7529.50
    Net Profit Margin (%)15.8914.3515.2525.2620.78
    Basic EPS (₹)1.811.591.472.341.91
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue3,067.002,511.202,223.551,671.091,340.10
    Total Revenue Growth (%)22.1312.9433.0624.7018.73
    Total Expenses2,519.702,051.291,753.471,223.741,061.09
    Total Expenses Growth (%)22.8316.9843.2915.337.38
    Profit after Tax (PAT)384.50310.15336.32332.69201.22
    PAT Growth (%)23.97-7.781.0965.3368.83
    Operating Profit Margin (%)21.0020.2922.7728.0623.42
    Net Profit Margin (%)12.6612.4115.3020.1515.12
    Basic EPS (₹)9.6138.7542.0341.8826.87
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue1,440.801,237.591,155.521,167.55942.30
    Total Revenue Growth (%)16.427.10-1.0323.9018.22
    Total Expenses1,048.50919.42818.19796.55688.04
    Total Expenses Growth (%)14.0412.372.7215.775.76
    Profit after Tax (PAT)302.90235.34252.49278.37188.65
    PAT Growth (%)28.71-6.79-9.3047.5655.77
    Operating Profit Margin (%)30.0126.3329.9032.8328.84
    Net Profit Margin (%)21.8819.2522.3024.3420.22
    Basic EPS (₹)7.5729.4131.5535.0425.20

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Beating 3 Yr Revenue CAGR

      Company's annual revenue growth of 28.16% outperformed its 3 year CAGR of 20.68%. (Source: Consolidated Financials)
    • Employee & Interest Expense

      Company has spent 5.19% of its operating revenues towards interest expenses and 17.46% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets5,736.003,852.022,941.301,907.351,436.15
    Total Assets Growth (%)48.9130.9654.2132.8120.09
    Total Liabilities3,317.201,758.781,003.34496.71559.96
    Total Liabilities Growth (%)88.6175.29102.00-11.30-4.19
    Total Equity2,418.802,093.241,937.961,410.64876.20
    Total Equity Growth (%)15.558.0137.3861.0043.30
    Current Ratio (x)0.831.211.611.831.62
    Total Debt to Equity (x)0.890.570.320.120.33
    Contingent Liabilities1,347.30555.71458.97103.5742.37
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets3,189.102,396.511,812.071,568.781,213.73
    Total Assets Growth (%)33.0732.2515.5129.2526.77
    Total Liabilities1,021.10530.05181.21191.24306.40
    Total Liabilities Growth (%)92.64192.51-5.24-37.58-8.07
    Total Equity2,168.001,866.451,630.861,377.55907.32
    Total Equity Growth (%)16.1614.4518.3951.8345.45
    Current Ratio (x)0.831.441.982.471.93
    Total Debt to Equity (x)0.330.170.000.010.13
    Contingent Liabilities521.80752.73762.85176.57164.25

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities581.80521.09432.09324.03355.97
    Net Cash used in Investing Activities-1,116.20-752.56-615.60-411.52-354.18
    Net Cash flow from Financing Activities543.10216.7688.3461.009.82
    Net Cash Flow9.10-14.7235.98-26.5011.62
    Closing Cash & Cash Equivalent56.0046.8961.6125.6352.13
    Closing Cash & Cash Equivalent Growth (%)19.43-23.89140.35-50.8328.67
    Total Debt/ CFO (x)3.282.011.230.500.80
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities293.60262.39269.96284.37291.35
    Net Cash used in Investing Activities-626.60-568.65-236.58-375.08-316.60
    Net Cash flow from Financing Activities338.60288.64-15.1475.9825.37
    Net Cash Flow5.60-17.6218.24-14.730.12
    Closing Cash & Cash Equivalent26.1020.4838.1019.8634.59
    Closing Cash & Cash Equivalent Growth (%)27.44-46.2491.85-42.580.34
    Total Debt/ CFO (x)2.411.240.020.060.41

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Increase in Cash from Investing

      Company has used Rs 1451.7 cr for investing activities which is an YoY increase of 30.06%. (Source: Consolidated Financials)
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)17.9816.9620.1423.9823.29
    Return on Capital Employed (%)13.0114.9118.9227.3826.90
    Return on Assets (%)6.708.0511.4317.4414.01
    Interest Coverage Ratio (x)9.0213.9020.6233.4311.73
    Asset Turnover Ratio (x)0.630.740.610.760.77
    Price to Earnings (x)66.6753.1933.5633.22-
    Price to Book (x)11.969.016.747.96-
    EV/EBITDA (x)33.9727.1419.0320.59-
    EBITDA Margin (%)26.8426.1528.6632.4728.65
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)13.9712.6015.4820.2020.79
    Return on Capital Employed (%)14.6714.7120.0026.1726.28
    Return on Assets (%)9.499.8213.9317.7415.54
    Interest Coverage Ratio (x)20.40103.89333.1494.0921.22
    Asset Turnover Ratio (x)0.500.580.670.820.86
    Price to Earnings (x)84.7570.4244.6439.68-
    Price to Book (x)11.808.826.908.02-
    EV/EBITDA (x)55.4744.1629.2325.89-
    EBITDA Margin (%)34.1831.0933.9036.7633.62

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

  • 5 Day EMA Crossover

    Bullish signal on daily chart

    Appeared on: 12 Jun 2026

    5D EMA: 775.72

    Last Signal 4 Jun 2026 (Gain 6.03%)

    Average price gain of 2.82% within 7 days of Bullish signal in last 5 years

    10 Day EMA Crossover

    Bullish signal on daily chart

    Appeared on: 12 Jun 2026

    10D EMA: 771.61

    Last Signal 4 Jun 2026 (Gain 6.03%)

    Average price gain of 2.90% within 7 days of Bullish signal in last 5 years

    Heikin-Ashi Changeover

    Bullish indication on daily chart

    • Prev. Close Price

      780.35

    • LTP

      785.10

    Formed on: 12 Jun 2026

    On daily price chart, Heikin-Ashi candle changed from Red to Green

    14 Day EMA Crossover

    Bullish signal on daily chart

    Appeared on: 11 Jun 2026

    14D EMA: 764.83

    Last Signal 4 Jun 2026 (Gain 6.03%)

    Average price gain of 2.84% within 7 days of Bullish signal in last 5 years

    MACD Crossover

    Bearish signal on daily chart

    Appeared on: 10 Jun 2026

    Region: Positive

    Last Signal 1 Jun 2026 (Loss -3.78%)

    Average price decline of -3.64% within 10 days of Bearish signal in last 10 years

  • 43%
    Positive Movement
    since 1st Jan 2005
    on basis
    56%
    Negative Movement
    since 1st Jan 2005
    on basis
    Exclude

    Global Meltdown1st Jan 2008 to 10th Nov 2008

    Covid Crisis1st Feb 2020 to 31st Mar 2020

  • R1791.60Pivot

    781.50

    S1775.00
    R2798.10S2764.90
    R3814.70S3748.30
  • 5 Days14 Days28 Days
    27.3228.1826.99

Found Technicals useful?

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters13,64,89,33034.11 %0.00
    Pledge1,40,00,00010.26 %6.60
    FII5,83,03,71514.57 %0.24
    DII12,95,74,32232.39 %-0.22
    MF10,96,62,42427.41 %-0.08
    Others7,57,71,56818.93 %0.00
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters34.1134.1134.1134.11
    Pledge10.263.660.000.00
    FII14.5714.3315.0315.54
    DII32.3932.6232.1231.65
    Mutual Funds27.4127.5026.7225.25
    Others18.9318.9318.7418.70

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Corporate Actions

  • Board Meeting

    Others

    Jun 10, 2026

    Board Meeting

    Audited Results

    May 06, 2026

    General Meeting

    -

    Mar 16, 2026

  • Announced onMeeting on
    Jun 10, 2026Jun 13, 2026
    Others
    May 06, 2026May 15, 2026
    Audited Results
    Mar 06, 2026Mar 11, 2026
    Rights Issue & Others
    Feb 02, 2026Feb 06, 2026
    Quarterly Results
    Oct 24, 2025Nov 07, 2025
    Quarterly Results
  • No Data Available

  • No Data Available

  • Announced onEx-Date
    Jun 28, 2024Sep 13, 2024
    Split: Old FV10.0| New FV:2.0
  • No Data Available

  • Announced onMeeting on
    Mar 16, 2026Apr 17, 2026
    -
    Jan 05, 2026Feb 03, 2026
    -
    Aug 08, 2025Aug 29, 2025
    -
    Feb 17, 2025Mar 18, 2025
    -
    Aug 07, 2024Aug 29, 2024
    -

About Krishna Instt of Medical Sciences

Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 31,414.91 Crore) operating in Hospitals & Allied Services sector.

Show More

Industry

Hospital

Key Indices Listed On

Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare

Address

D.No. 1-8-31/1,Minister Road,Secunderabad, Telangana - 500003

Executive Leadership

BR

Bhaskara Rao Bollineni

Chairman & Managing Director
AB

Abhinay Bollineni

Executive Director & CEO
AD

Anitha Dandamudi

Whole Time Director
AB

Adwik Bollineni

Non Executive Director
Show More

Auditors

S R Batliboi & Associates LLP

FAQs about Krishna Instt of Medical Sciences share

  • 1. What is Krishna Instt of Medical Sciences share price and what are the returns for Krishna Instt of Medical Sciences share?
    Krishna Instt of Medical Sciences share price is Rs 785.10 as on 12 Jun, 2026, 03:52 PM IST. Krishna Instt of Medical Sciences share price is up by 2.58% based on previous share price of Rs 763.15. Krishna Instt of Medical Sciences share price trend:
    • Last 12 Months: Krishna Instt of Medical Sciences share price moved up 18.72%
    • Last 3 Years: Krishna Instt of Medical Sciences Share price moved up by 143.80%
  • 2. What is 52 week high/low of Krishna Instt of Medical Sciences share price?
    Krishna Instt of Medical Sciences share price saw a 52 week high of Rs 811.00 and 52 week low of Rs 575.80.
  • 3. What are the returns for Krishna Instt of Medical Sciences share?
    Return Performance of Krishna Instt of Medical Sciences Shares:
    • 1 Week: Krishna Instt of Medical Sciences share price moved down by 0.49%
  • 4. What is the PE & PB ratio of Krishna Instt of Medical Sciences?
    The PE ratio of Krishna Instt of Medical Sciences stands at 126.87, while the PB ratio is 11.97.
  • 5. What's the market capitalization of Krishna Instt of Medical Sciences?
    Within the Hospitals & Allied Services sector, Krishna Instt of Medical Sciences stock has a market cap rank of 7. Krishna Instt of Medical Sciences has a market cap of Rs 31,414.91 Cr.

Top Gainers

As on 04:06 PM | 12 Jun 2026
Ather Energy
1,028.70
714.90 (227.82%)
Netweb Technologies
4,587.40
2780.60 (153.90%)
Syrma SGS Technology
1,266.70
737.70 (139.45%)
Vodafone Idea
14.90
8.12 (119.76%)
GE T&D India
4,942.50
2633.90 (114.09%)

Top Losers

As on 03:58 PM | 12 Jun 2026
Tata Investment
665.90
-6218.10 (-90.33%)
Angel One
339.50
-2678.10 (-88.75%)
CAMS
757.55
-3315.15 (-81.40%)
Kotak Bank
403.30
-1723.50 (-81.04%)
Authum Investment
530.15
-1967.65 (-78.78%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.